![](/images/general/no_picture/200_user.png)
Geraldina Visconti
Examiner (ID: 121, Phone: (571)272-1334 , Office: P/1722 )
Most Active Art Unit | 1722 |
Art Unit(s) | 1506, 1795, 1752, 1113, 1722 |
Total Applications | 2553 |
Issued Applications | 2180 |
Pending Applications | 89 |
Abandoned Applications | 284 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7470358
[patent_doc_number] => 20040121365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Double and triple readout assay systems'
[patent_app_type] => new
[patent_app_number] => 10/624618
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7292
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624618 | Double and triple readout assay systems | Jul 21, 2003 | Abandoned |
Array
(
[id] => 7439876
[patent_doc_number] => 20040009160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-15
[patent_title] => 'Bioactive food complex, method for making bioactive food complex product and method for controlling disease'
[patent_app_type] => new
[patent_app_number] => 10/312039
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8164
[patent_no_of_claims] => 92
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20040009160.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312039
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312039 | Bioactive food complex, method for making bioactive food complex product and method for controlling disease | Jul 14, 2003 | Abandoned |
Array
(
[id] => 925627
[patent_doc_number] => 07316925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Codon optimized synthetic plasmids'
[patent_app_type] => utility
[patent_app_number] => 10/619939
[patent_app_country] => US
[patent_app_date] => 2003-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12905
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/316/07316925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619939
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619939 | Codon optimized synthetic plasmids | Jul 14, 2003 | Issued |
Array
(
[id] => 7236203
[patent_doc_number] => 20040073956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Assay techniques based on growth stage dependent expression inc. elegans'
[patent_app_type] => new
[patent_app_number] => 10/297192
[patent_app_country] => US
[patent_app_date] => 2003-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 10610
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297192 | Assay techniques based on growth stage dependent expression inc. elegans | Jul 10, 2003 | Abandoned |
Array
(
[id] => 7449382
[patent_doc_number] => 20040067543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Multi-disciplinary approach to validating or identifying targets using an in vivo system'
[patent_app_type] => new
[patent_app_number] => 10/610821
[patent_app_country] => US
[patent_app_date] => 2003-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8542
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10610821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/610821 | Multi-disciplinary approach to validating or identifying targets using an in vivo system | Jul 1, 2003 | Abandoned |
Array
(
[id] => 7251931
[patent_doc_number] => 20050074767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-07
[patent_title] => 'Genes associated with obesity and methods for using the same'
[patent_app_type] => utility
[patent_app_number] => 10/608865
[patent_app_country] => US
[patent_app_date] => 2003-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30358
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20050074767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10608865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/608865 | Genes associated with obesity and methods for using the same | Jun 26, 2003 | Abandoned |
Array
(
[id] => 6665532
[patent_doc_number] => 20030204859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Animal model of polyglutamine toxicity, methods of use, and modulators of polyglutamine toxicity'
[patent_app_type] => new
[patent_app_number] => 10/465217
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 172
[patent_figures_cnt] => 172
[patent_no_of_words] => 32993
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20030204859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465217
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465217 | Animal model of polyglutamine toxicity, methods of use, and modulators of polyglutamine toxicity | Jun 17, 2003 | Abandoned |
Array
(
[id] => 7134643
[patent_doc_number] => 20040043403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Process for determining the biological activity of epidermal growth factor receptor tyrosine kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/450801
[patent_app_country] => US
[patent_app_date] => 2003-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6894
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043403.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450801 | Process for determining the biological activity of epidermal growth factor receptor tyrosine kinase inhibitors | Jun 15, 2003 | Abandoned |
Array
(
[id] => 6724939
[patent_doc_number] => 20030207251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-06
[patent_title] => 'Method for testing a therapeutic of preventive agent for hyperlipidemia'
[patent_app_type] => new
[patent_app_number] => 10/460125
[patent_app_country] => US
[patent_app_date] => 2003-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24810
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20030207251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460125
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460125 | Method for testing a therapeutic of preventive agent for hyperlipidemia | Jun 10, 2003 | Abandoned |
Array
(
[id] => 6634222
[patent_doc_number] => 20030211533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Method for testing a therapeutic or preventive agent for hyperlipidemia'
[patent_app_type] => new
[patent_app_number] => 10/460124
[patent_app_country] => US
[patent_app_date] => 2003-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24803
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10460124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/460124 | Method for testing a therapeutic or preventive agent for hyperlipidemia | Jun 10, 2003 | Abandoned |
Array
(
[id] => 5813825
[patent_doc_number] => 20060084054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => utility
[patent_app_number] => 10/455772
[patent_app_country] => US
[patent_app_date] => 2003-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 367908
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10455772
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/455772 | Novel proteins and nucleic acids encoding same | Jun 3, 2003 | Abandoned |
Array
(
[id] => 575412
[patent_doc_number] => 07455988
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-25
[patent_title] => 'Inducible eukaryotic expression system'
[patent_app_type] => utility
[patent_app_number] => 10/447243
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6681
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/455/07455988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447243 | Inducible eukaryotic expression system | May 27, 2003 | Issued |
Array
(
[id] => 6701096
[patent_doc_number] => 20030223976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Control sequences of the human corin gene'
[patent_app_type] => new
[patent_app_number] => 10/447476
[patent_app_country] => US
[patent_app_date] => 2003-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14943
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20030223976.pdf
[firstpage_image] =>[orig_patent_app_number] => 10447476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/447476 | Control sequences of the human corin gene | May 27, 2003 | Abandoned |
Array
(
[id] => 7347608
[patent_doc_number] => 20040248097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Interleukin-20 variants and promoters'
[patent_app_type] => new
[patent_app_number] => 10/444765
[patent_app_country] => US
[patent_app_date] => 2003-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7984
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10444765
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/444765 | Interleukin-20 variants and promoters | May 22, 2003 | Abandoned |
Array
(
[id] => 5807653
[patent_doc_number] => 20060094007
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc'
[patent_app_type] => utility
[patent_app_number] => 10/514235
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24238
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094007.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514235 | Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc | May 21, 2003 | Abandoned |
Array
(
[id] => 7364801
[patent_doc_number] => 20040005639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Glycerylaldehyde-3-phosphate dehyrogenase promoter inducing cell death'
[patent_app_type] => new
[patent_app_number] => 10/343921
[patent_app_country] => US
[patent_app_date] => 2003-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3091
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343921
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343921 | Glycerylaldehyde-3-phosphate dehyrogenase promoter inducing cell death | May 20, 2003 | Abandoned |
Array
(
[id] => 7474604
[patent_doc_number] => 20040055024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Conditional mutants of influenza virus M2 protein'
[patent_app_type] => new
[patent_app_number] => 10/435723
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20040055024.pdf
[firstpage_image] =>[orig_patent_app_number] => 10435723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/435723 | Conditional mutants of influenza virus M2 protein | May 7, 2003 | Abandoned |
Array
(
[id] => 6865207
[patent_doc_number] => 20030190733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Desaturase genes and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/431952
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19533
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431952 | Desaturase genes and uses thereof | May 7, 2003 | Issued |
Array
(
[id] => 7019459
[patent_doc_number] => 20050221478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Control of es cell self renewal and lineage specification, and medium therefor'
[patent_app_type] => utility
[patent_app_number] => 10/513675
[patent_app_country] => US
[patent_app_date] => 2003-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5810
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221478.pdf
[firstpage_image] =>[orig_patent_app_number] => 10513675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/513675 | Control of es cell self renewal and lineage specification, and medium therefor | May 7, 2003 | Abandoned |
Array
(
[id] => 6701642
[patent_doc_number] => 20030224522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Methods for delivering nucleic acid molecules into cells and assessment thereof'
[patent_app_type] => new
[patent_app_number] => 10/428653
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31440
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224522.pdf
[firstpage_image] =>[orig_patent_app_number] => 10428653
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/428653 | Methods for delivering nucleic acid molecules into cells and assessment thereof | Apr 30, 2003 | Abandoned |